Breaking News Instant updates and real-time market news.

BIIB

Biogen

$286.22 /

+0.16 (+0.06%)

, ESALY

Eisai

$74.25 /

+6.82 (+10.11%)

13:08
06/07/21
06/07
13:08
06/07/21
13:08

Biogen says value-based pacts in progress with Cigna, other payers for Aduhelm

Following today's U.S. Food and Drug Administration's accelerated approval of Aduhelm as "the first and only Alzheimer's disease treatment to address a defining pathology of the disease by reducing amyloid beta plaques in the brain," Biogen (BIIB) and Eisai Inc., U.S. subsidiary of Eisai Co. (ESALY), announced a range of programs intended to support access for all qualified patients, including traditionally underserved populations. "These initiatives aim to help patients and their families understand the disease, navigate the diagnostic journey, secure culturally competent care and afford treatment," the companies stated. Biogen and Eisai have established a program with Labcorp (LH) and Mayo Clinic Laboratories to help physicians and patients access cerebrospinal fluid, or CSF, diagnostic laboratory testing to aid in the diagnosis of Alzheimer's disease, the companies said. With the Veterans Health Administration, or VHA, Biogen is working to finalize a multi-year agreement in order to support access for veterans throughout the VHA system. Biogen has also entered into an initiative with CVS Health (CVS) focused on the importance of brain health, screening and disease education. As part of this effort, cognitive screenings will be available through CVS Health's Project Health, a longstanding health services program helping address care disparities for uninsured and underinsured Americans, particularly in racially and ethnically diverse communities.The program is scheduled to begin in September in the following cities: Atlanta, Boston/Providence, Charlotte, Charleston/Columbia, Chicago, Dallas/Fort Worth, Detroit, Houston, Jackson/Memphis, Los Angeles, Miami, New York City, Philadelphia, and Washington DC. The companies said they have been working closely with payers to prepare them for the launch of Aduhelm and support patient access. In that regard, Biogen and Cigna Corporation (CI), a global health service company, intend to enter into a value-based contract to "ensure that there is a streamlined path to access treatment for patients consistent with the population in which Aduhelm was studied," the company said. The parties will also be tracking performance towards certain outcome metrics for patients. Biogen and Eisai have committed to not increasing the price of Aduhelm for the next four years, the companies added.

BIIB

Biogen

$286.22 /

+0.16 (+0.06%)

ESALY

Eisai

$74.25 /

+6.82 (+10.11%)

CI

Cigna

$248.38 /

-3.515 (-1.40%)

CVS

CVS Health

$86.83 /

+0.34 (+0.39%)

LH

LabCorp

$263.17 /

-3.23 (-1.21%)

  • 07

    Jun

  • 05

    Aug

BIIB Biogen
$286.22 /

+0.16 (+0.06%)

06/07/21 Piper Sandler
Biogen price target raised to $384 from $260 at Piper Sandler
06/07/21 Goldman Sachs
Goldman says Biogen approval has positive read to Alector, Athira
06/07/21 Jefferies
Athira Pharma could rise 25-50% in short-term after Biogen news, says Jefferies
06/07/21 Stifel
Stifel says Biogen questions to be debated at 'materially higher' valuation
ESALY Eisai
$74.25 /

+6.82 (+10.11%)

01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
11/05/20 Jefferies
Eisai upgraded to Buy from Hold at Jefferies
09/08/20 Jefferies
Eisai downgraded to Hold from Buy at Jefferies
CI Cigna
$248.38 /

-3.515 (-1.40%)

05/18/21 Wells Fargo
Cigna initiated with an Equal Weight at Wells Fargo
05/14/21 RBC Capital
Cigna price target raised to $304 from $265 at RBC Capital
05/10/21 Credit Suisse
Cigna price target raised to $300 from $270 at Credit Suisse
05/10/21 BMO Capital
Cigna price target raised to $315 from $300 at BMO Capital
CVS CVS Health
$86.83 /

+0.34 (+0.39%)

05/27/21 Mizuho
CVS, Walgreens selloff on Amazon report overdone, says Mizuho
05/26/21 Deutsche Bank
Amazon unlikely to enter retail pharmacy business, says Deutsche Bank
05/19/21 BMO Capital
CVS Health price target raised to $96 from $90 at BMO Capital
05/19/21 Barclays
CVS Health price target raised to $100 from $92 at Barclays
LH LabCorp
$263.17 /

-3.23 (-1.21%)

05/20/21 Argus
LabCorp price target raised to $295 from $270 at Argus
05/18/21 Wells Fargo
Amazon could have interest in diagnostics beyond COVID, says Wells Fargo
05/12/21 Mizuho
LabCorp price target raised to $310 from $267 at Mizuho
05/03/21 William Blair
LabCorp's Vectra deal likely not the last for this year, says William Blair

TODAY'S FREE FLY STORIES

Initiation
Beauty Health initiated with an Overweight at Piper Sandler » 21:34
06/23/21
06/23
21:34
06/23/21
21:34
SKIN

Beauty Health

$17.60 /

+0.21 (+1.21%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SKIN Beauty Health
$17.60 /

+0.21 (+1.21%)

SKIN Beauty Health
$17.60 /

+0.21 (+1.21%)

06/15/21 Canaccord
Canaccord starts 'category creator' Beauty Health with Buy, $21 target
06/15/21 Canaccord
Beauty Health initiated with a Buy at Canaccord
SKIN Beauty Health
$17.60 /

+0.21 (+1.21%)

SKIN Beauty Health
$17.60 /

+0.21 (+1.21%)

Syndicate
OneSpaWorld 8.42M share Spot Secondary priced at $9.50 » 20:49
06/23/21
06/23
20:49
06/23/21
20:49
OSW

OneSpaWorld

$10.20 /

-1 (-8.93%)

The deal was priced below…

The deal was priced below last closing price of $10.20. Stifel and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
OSW OneSpaWorld
$10.20 /

-1 (-8.93%)

OSW OneSpaWorld
$10.20 /

-1 (-8.93%)

03/24/21 Stifel
Cruiseline stock selloff 'unwarranted,' says Stifel
01/13/21 Jefferies
OneSpaWorld downgraded to Hold at Jefferies following over 50% rally
01/13/21 Jefferies
OneSpaWorld downgraded to Hold from Buy at Jefferies
10/30/20 Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
OSW OneSpaWorld
$10.20 /

-1 (-8.93%)

  • 24
    Jun
OSW OneSpaWorld
$10.20 /

-1 (-8.93%)

OSW OneSpaWorld
$10.20 /

-1 (-8.93%)

Initiation
Okta initiated with a Buy at Daiwa » 20:46
06/23/21
06/23
20:46
06/23/21
20:46
OKTA

Okta

$242.62 /

+1.34 (+0.56%)

Daiwa analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OKTA Okta
$242.62 /

+1.34 (+0.56%)

OKTA Okta
$242.62 /

+1.34 (+0.56%)

05/27/21 Canaccord
Okta becoming the standard for digital identity, says Canaccord
05/27/21 JPMorgan
Okta price target raised to $245 from $235 at JPMorgan
05/27/21 Mizuho
Okta 'nicely exceeded' billings growth forecast, says Mizuho
05/27/21 Piper Sandler
Piper Sandler sees a 'little uncertainty' following Q1 beat by Okta
OKTA Okta
$242.62 /

+1.34 (+0.56%)

OKTA Okta
$242.62 /

+1.34 (+0.56%)

OKTA Okta
$242.62 /

+1.34 (+0.56%)

OKTA Okta
$242.62 /

+1.34 (+0.56%)

Initiation
Skillsoft initiated with a Buy at B. Riley » 20:46
06/23/21
06/23
20:46
06/23/21
20:46
SKIL

Skillsoft

$9.73 /

-0.275 (-2.75%)

B. Riley initiated…

B. Riley initiated coverage of Skillsoft with a Buy rating and $14 price target.

ShowHide Related Items >><<
SKIL Skillsoft
$9.73 /

-0.275 (-2.75%)

SKIL Skillsoft
$9.73 /

-0.275 (-2.75%)

06/22/21 Citi
Skillsoft initiated with a Buy at Citi
SKIL Skillsoft
$9.73 /

-0.275 (-2.75%)

Hot Stocks
Myan wins summary judgment ruling in Kansas EpiPen class action » 20:25
06/23/21
06/23
20:25
06/23/21
20:25
MYL

Symbol now VTRS

$15.86 /

+ (+0.00%)

, VTRS

Viatris

$14.18 /

-0.04 (-0.28%)

Viatris (VTRS) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VTRS Viatris
$14.18 /

-0.04 (-0.28%)

MYL Symbol now VTRS
$15.86 /

+ (+0.00%)

11/06/20 Cowen
Mylan merger with Upjohn 'will likely solve nothing,' says Cowen
09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
09/16/20 Raymond James
Mylan exclusivity on Tecfidera generic abruptly ending, says Raymond James
08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
VTRS Viatris
$14.18 /

-0.04 (-0.28%)

06/15/21 Citi
Viatris initiated with a Neutral at Citi
04/06/21 RBC Capital
Viatris transferred with an Outperform at RBC Capital
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
03/12/21 Piper Sandler
Viatris price target lowered to $16 from $17 at Piper Sandler
VTRS Viatris
$14.18 /

-0.04 (-0.28%)

VTRS Viatris
$14.18 /

-0.04 (-0.28%)

Syndicate
Monte Rosa Therapeutics 11.7M share IPO priced at $19.00 » 20:24
06/23/21
06/23
20:24
06/23/21
20:24
GLUE

Monte Rosa Therapeutics

/

+

The deal size was…

The deal size was increased to 11.7M shares from 9.75M and priced at high end of $17.00-$19.00 range. JPMorgan, Cowen, Piper Sandler and Guggenheim are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 24
    Jun
Syndicate
Bon Natural Life prices 2.2M share IPO at $5.00 » 20:02
06/23/21
06/23
20:02
06/23/21
20:02
BON

Bon Natural Life

$20.58 /

+ (+0.00%)

U.S. Tiger Securities,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Grove prices 2.2M share IPO at $5.00 per share » 19:48
06/23/21
06/23
19:48
06/23/21
19:48
GRVI

Grove

/

+

The company has received…

The company has received approval to list its common stock on the Nasdaq Capital Market under the symbol "GRVI", with trading expected to begin on June 24, 2021. EF Hutton, division of Benchmark Investments, LLC, is acting as the sole book-running manager for the offering.

ShowHide Related Items >><<
    Periodicals
    JPMorgan tells staff they may be required to get vaccinated, Bloomberg says  19:22
    06/23/21
    06/23
    19:22
    06/23/21
    19:22
    JPM

    JPMorgan

    $151.12 /

    +0.91 (+0.61%)

     
    ShowHide Related Items >><<
    JPM JPMorgan
    $151.12 /

    +0.91 (+0.61%)

    JPM JPMorgan
    $151.12 /

    +0.91 (+0.61%)

    06/15/21 BMO Capital
    JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view
    06/14/21 Evercore ISI
    Synchrony price target raised to $56 from $49 at Evercore ISI
    06/08/21 Wells Fargo
    JPMorgan price target raised to $200 from $195 at Wells Fargo
    05/06/21 JMP Securities
    Walker & Dunlop price target raised to $130 from $70 at JMP Securities
    JPM JPMorgan
    $151.12 /

    +0.91 (+0.61%)

    JPM JPMorgan
    $151.12 /

    +0.91 (+0.61%)

    JPM JPMorgan
    $151.12 /

    +0.91 (+0.61%)

    JPM JPMorgan
    $151.12 /

    +0.91 (+0.61%)

    Upgrade
    GlaxoSmithKline upgraded to Hold from Sell at Deutsche Bank » 19:21
    06/23/21
    06/23
    19:21
    06/23/21
    19:21
    GSK

    GlaxoSmithKline

    $39.86 /

    +0.78 (+2.00%)

    Deutsche Bank analyst…

    Deutsche Bank analyst Emmanuel Papadakis upgraded GlaxoSmithKline to Hold from Sell with a 1,350 GBp price target.

    ShowHide Related Items >><<
    GSK GlaxoSmithKline
    $39.86 /

    +0.78 (+2.00%)

    GSK GlaxoSmithKline
    $39.86 /

    +0.78 (+2.00%)

    06/14/21 Piper Sandler
    iTeos deal 'addresses a number of needs all at once, says Piper Sandler
    06/11/21 Deutsche Bank
    GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
    05/27/21 Piper Sandler
    Xencorc royalty revenue streams growing, says Piper Sandler
    05/11/21 UBS
    GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
    GSK GlaxoSmithKline
    $39.86 /

    +0.78 (+2.00%)

    GSK GlaxoSmithKline
    $39.86 /

    +0.78 (+2.00%)

    GSK GlaxoSmithKline
    $39.86 /

    +0.78 (+2.00%)

    GSK GlaxoSmithKline
    $39.86 /

    +0.78 (+2.00%)

    Hot Stocks
    Japan's PMDA renews Certara's biosimulation software license » 19:03
    06/23/21
    06/23
    19:03
    06/23/21
    19:03
    CERT

    Certara

    $26.38 /

    -0.81 (-2.98%)

    Certara announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    CERT Certara
    $26.38 /

    -0.81 (-2.98%)

    CERT Certara
    $26.38 /

    -0.81 (-2.98%)

    05/07/21 Barclays
    Certara price target lowered to $35 from $40 at Barclays
    03/02/21 Barclays
    Certara initiated with an Overweight at Barclays
    03/02/21 Barclays
    Certara initiated with an Overweight at Barclays
    01/05/21 Morgan Stanley
    Morgan Stanley starts Certara at Equal Weight, says fully valued
    CERT Certara
    $26.38 /

    -0.81 (-2.98%)

    • 25
      Mar
    • 11
      Dec
    CERT Certara
    $26.38 /

    -0.81 (-2.98%)

    CERT Certara
    $26.38 /

    -0.81 (-2.98%)

    On The Fly
    Fly Intel: After-Hours Movers » 18:58
    06/23/21
    06/23
    18:58
    06/23/21
    18:58
    SCS

    Steelcase

    $14.49 /

    +0.04 (+0.28%)

    , RCUS

    Arcus Biosciences

    $23.40 /

    +0.67 (+2.95%)

    , FSP

    Franklin Street

    $5.27 /

    -0.13 (-2.41%)

    , KBH

    KB Home

    $43.35 /

    +0.1 (+0.23%)

    , CNXC

    Concentrix

    $157.11 /

    +2.23 (+1.44%)

    , FUL

    H.B. Fuller

    $65.62 /

    -0.885 (-1.33%)

    , PRTG

    Portage Biotech

    $35.28 /

    +2.38 (+7.23%)

    , BNL

    Broadstone Net Lease

    $24.08 /

    +0.37 (+1.56%)

    , TALO

    Talos Energy

    $18.60 /

    +0.47 (+2.59%)

    , BYND

    Beyond Meat

    $147.37 /

    -0.47 (-0.32%)

    Check out this evening's…

    ShowHide Related Items >><<
    TALO Talos Energy
    $18.60 /

    +0.47 (+2.59%)

    SCS Steelcase
    $14.49 /

    +0.04 (+0.28%)

    RCUS Arcus Biosciences
    $23.40 /

    +0.67 (+2.95%)

    KBH KB Home
    $43.35 /

    +0.1 (+0.23%)

    FUL H.B. Fuller
    $65.62 /

    -0.885 (-1.33%)

    FSP Franklin Street
    $5.27 /

    -0.13 (-2.41%)

    CNXC Concentrix
    $157.11 /

    +2.23 (+1.44%)

    BYND Beyond Meat
    $147.37 /

    -0.47 (-0.32%)

    BNL Broadstone Net Lease
    $24.08 /

    +0.37 (+1.56%)

    SCS Steelcase
    $14.49 /

    +0.04 (+0.28%)

    05/11/21 Berenberg
    Berenberg starts 'market leader' Steelcase at Buy
    05/11/21 Berenberg
    Steelcase initiated with a Buy at Berenberg
    05/07/21 Benchmark
    Benchmark upgrades Steelcase to Buy on signs of recovery in commercial furniture
    05/07/21 Benchmark
    Steelcase upgraded to Buy from Hold at Benchmark
    RCUS Arcus Biosciences
    $23.40 /

    +0.67 (+2.95%)

    02/25/21 Barclays
    Arcus Biosciences price target raised to $45 from $40 at Barclays
    02/25/21 Mizuho
    Arcus Biosciences price target raised to $43 from $40 at Mizuho
    01/20/21 Citi
    Arcus Biosciences price target raised to $51 from $32 at Citi
    01/19/21 Wedbush
    Arcus Biosciences price target raised to $55 from $48 at Wedbush
    FSP Franklin Street
    $5.27 /

    -0.13 (-2.41%)

    KBH KB Home
    $43.35 /

    +0.1 (+0.23%)

    06/15/21 Wedbush
    Wedbush sees pullback in KB Home shares as buying opportunity
    04/15/21 Wells Fargo
    KB Home initiated with an Overweight at Wells Fargo
    03/29/21 Argus
    KB Home's new orders were 'stellar', says Argus
    03/25/21 Keefe Bruyette
    KB Home price target raised to $48 from $44 at Keefe Bruyette
    CNXC Concentrix
    $157.11 /

    +2.23 (+1.44%)

    06/15/21 Barrington
    Concentrix initiated with an Outperform at Barrington
    01/07/21 Cross Research
    Concentrix initiated with a Buy at Cross Research
    12/08/20 Stifel
    Synnex downgraded to Hold from Buy at Stifel
    12/07/20 BofA
    Concentrix initiated with a Buy at BofA
    FUL H.B. Fuller
    $65.62 /

    -0.885 (-1.33%)

    03/29/21 Deutsche Bank
    H.B. Fuller price target raised to $65 from $56 at Deutsche Bank
    03/26/21 Baird
    H.B. Fuller price target raised to $72 from $65 at Baird
    01/27/21 Deutsche Bank
    H.B. Fuller price target raised to $56 from $48 at Deutsche Bank
    01/04/21 Baird
    H.B. Fuller upgraded to Outperform, added to 2021 top picks at Baird
    PRTG Portage Biotech
    $35.28 /

    +2.38 (+7.23%)

    BNL Broadstone Net Lease
    $24.08 /

    +0.37 (+1.56%)

    06/22/21 BTIG
    Broadstone Net Lease price target raised to $27 from $21 at BTIG
    06/17/21 Goldman Sachs
    Broadstone Net Lease downgraded to Neutral from Buy at Goldman Sachs
    06/15/21
    Fly Intel: Top five analyst downgrades
    06/15/21 JPMorgan
    JPMorgan upgrades W.P. Carey on swap out of Broadstone
    TALO Talos Energy
    $18.60 /

    +0.47 (+2.59%)

    06/08/21
    Fly Intel: Top five analyst initiations
    06/08/21 Citi
    Talos Energy initiated with a Buy at Citi
    05/03/21 Roth Capital
    Talos Energy price target raised to $18 from $13 at Roth Capital
    04/13/21 Stifel
    BP discovery holds over 100MMboe of potential net to Talos interest, says Stifel
    BYND Beyond Meat
    $147.37 /

    -0.47 (-0.32%)

    16:11 Today JPMorgan
    Beyond Meat breakfast sandwich discontinued at Dunkin', says JPMorgan
    05/24/21
    Fly Intel: Top five analyst upgrades
    05/24/21 Bernstein
    Beyond Meat upgraded to Outperform from Underperform at Bernstein
    05/11/21 Barclays
    Beyond Meat price target lowered to $90 from $100 at Barclays
    TALO Talos Energy
    $18.60 /

    +0.47 (+2.59%)

    SCS Steelcase
    $14.49 /

    +0.04 (+0.28%)

    RCUS Arcus Biosciences
    $23.40 /

    +0.67 (+2.95%)

    KBH KB Home
    $43.35 /

    +0.1 (+0.23%)

    FUL H.B. Fuller
    $65.62 /

    -0.885 (-1.33%)

    CNXC Concentrix
    $157.11 /

    +2.23 (+1.44%)

    BYND Beyond Meat
    $147.37 /

    -0.47 (-0.32%)

    BNL Broadstone Net Lease
    $24.08 /

    +0.37 (+1.56%)

    • 24
      Jun
    • 24
      Jun
    • 24
      Jun
    • 09
      Dec
    • 17
      Sep
    TALO Talos Energy
    $18.60 /

    +0.47 (+2.59%)

    KBH KB Home
    $43.35 /

    +0.1 (+0.23%)

    BYND Beyond Meat
    $147.37 /

    -0.47 (-0.32%)

    TALO Talos Energy
    $18.60 /

    +0.47 (+2.59%)

    SCS Steelcase
    $14.49 /

    +0.04 (+0.28%)

    KBH KB Home
    $43.35 /

    +0.1 (+0.23%)

    FUL H.B. Fuller
    $65.62 /

    -0.885 (-1.33%)

    BYND Beyond Meat
    $147.37 /

    -0.47 (-0.32%)

    SCS Steelcase
    $14.49 /

    +0.04 (+0.28%)

    KBH KB Home
    $43.35 /

    +0.1 (+0.23%)

    FUL H.B. Fuller
    $65.62 /

    -0.885 (-1.33%)

    CNXC Concentrix
    $157.11 /

    +2.23 (+1.44%)

    BYND Beyond Meat
    $147.37 /

    -0.47 (-0.32%)

    Hot Stocks
    IGC completes final cohort of Phase 1 trial on Alzheimer's patients » 18:54
    06/23/21
    06/23
    18:54
    06/23/21
    18:54
    IGC

    India Globalization Capital

    $1.46 /

    -0.01 (-0.68%)

    India Globalization…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IGC India Globalization Capital
    $1.46 /

    -0.01 (-0.68%)

    IGC India Globalization Capital
    $1.46 /

    -0.01 (-0.68%)

    03/29/21 Stifel
    Stifel says New York adult use cannabis market represents $5B opportunity
    02/02/21 Craig-Hallum
    Legalization could drive '3x upside' for U.S. cannabis stocks, says Craig-Hallum
    01/29/21 Stifel
    'Goldilocks' scenario for U.S. cannabis industry in play, says Stifel
    12/04/20 Alliance Global Partners
    Alliance Global sees low odds of MORE Act passing this congressional session
    IGC India Globalization Capital
    $1.46 /

    -0.01 (-0.68%)

    IGC India Globalization Capital
    $1.46 /

    -0.01 (-0.68%)

    IGC India Globalization Capital
    $1.46 /

    -0.01 (-0.68%)

    Hot Stocks
    Box CEO: We're executing a very effective strategy » 18:48
    06/23/21
    06/23
    18:48
    06/23/21
    18:48
    BOX

    Box

    $25.22 /

    +0.02 (+0.08%)

    In an interview on…

    In an interview on CNBC's Mad Money, Aaron Levie said Box has been executing its plan to drive higher operating margins and growth rates. "We fundamentally believe there is significant upside to our stock," he added. The company did a full strategic review recently to identify what could be done to drive shareholder value, Levie noted. Box has spent a tremendous amount of time with Starboard and has listened to their ideas, he added. "We fundamentally believe as a board we have the right path forward. We don't believe board changes are warranted," Levie said.

    ShowHide Related Items >><<
    BOX Box
    $25.22 /

    +0.02 (+0.08%)

    BOX Box
    $25.22 /

    +0.02 (+0.08%)

    04/09/21 DA Davidson
    Box price target lowered to $22 from $25 at DA Davidson
    04/09/21 William Blair
    KKR investment 'strong vote of confidence' in Box, says William Blair
    04/09/21 William Blair
    KKR investment 'strong vote of confidence' in Box, says William Blair
    03/23/21 KeyBanc
    Box price target raised to $27 from $22 at KeyBanc
    BOX Box
    $25.22 /

    +0.02 (+0.08%)

    BOX Box
    $25.22 /

    +0.02 (+0.08%)

    BOX Box
    $25.22 /

    +0.02 (+0.08%)

    BOX Box
    $25.22 /

    +0.02 (+0.08%)

    Hot Stocks
    J.M. Smucker CEO sells 10K shares of common stock » 18:44
    06/23/21
    06/23
    18:44
    06/23/21
    18:44
    SJM

    J.M. Smucker

    $129.06 /

    -1.42 (-1.09%)

    In a regulatory filing,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SJM J.M. Smucker
    $129.06 /

    -1.42 (-1.09%)

    SJM J.M. Smucker
    $129.06 /

    -1.42 (-1.09%)

    06/04/21 Stifel
    J.M. Smucker price target raised to $135 from $125 at Stifel
    06/04/21 Deutsche Bank
    J.M. Smucker price target raised to $140 from $138 at Deutsche Bank
    06/04/21 BofA
    J.M. Smucker price target raised to $140 from $124 at BofA
    05/20/21 Deutsche Bank
    J.M. Smucker named 'Catalyst Call: Buy Idea' at Deutsche Bank
    SJM J.M. Smucker
    $129.06 /

    -1.42 (-1.09%)

    SJM J.M. Smucker
    $129.06 /

    -1.42 (-1.09%)

    SJM J.M. Smucker
    $129.06 /

    -1.42 (-1.09%)

    SJM J.M. Smucker
    $129.06 /

    -1.42 (-1.09%)

    Upgrade
    Magna upgraded to Buy from Neutral at Goldman Sachs » 18:42
    06/23/21
    06/23
    18:42
    06/23/21
    18:42
    MGA

    Magna

    $92.86 /

    +0.24 (+0.26%)

    Goldman Sachs analyst…

    Goldman Sachs analyst Mark DeLaney upgraded Magna to Buy from Neutral with a price target of $120, up from $97. The analyst said his view on the stock is driven by the company's ability to support new market entrants, growing EV businesses, and a "reasonable" valuation. DeLaney believes Magna's broad set of capabilities position it well to be a key provider for new market entrants.

    ShowHide Related Items >><<
    MGA Magna
    $92.86 /

    +0.24 (+0.26%)

    MGA Magna
    $92.86 /

    +0.24 (+0.26%)

    06/21/21 Edward Jones
    Magna upgraded to Buy from Hold at Edward Jones
    05/31/21 BMO Capital
    Magna price target raised to $115 from $108 at BMO Capital
    05/10/21 Credit Suisse
    Magna price target raised to $120 from $115 at Credit Suisse
    04/20/21 Morgan Stanley
    Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
    MGA Magna
    $92.86 /

    +0.24 (+0.26%)

    MGA Magna
    $92.86 /

    +0.24 (+0.26%)

    MGA Magna
    $92.86 /

    +0.24 (+0.26%)

    MGA Magna
    $92.86 /

    +0.24 (+0.26%)

    Recommendations
    Patterson Companies price target lowered to $41 from $44 at Piper Sandler » 18:39
    06/23/21
    06/23
    18:39
    06/23/21
    18:39
    PDCO

    Patterson Companies

    $30.95 /

    -4.18 (-11.90%)

    Piper Sandler analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PDCO Patterson Companies
    $30.95 /

    -4.18 (-11.90%)

    PDCO Patterson Companies
    $30.95 /

    -4.18 (-11.90%)

    08:42 Today Piper Sandler
    Patterson earnings pullback a buying opportunity, says Piper Sandler
    06/17/21
    Fly Intel: Top five analyst upgrades
    06/17/21 Piper Sandler
    Patterson Companies upgraded to Overweight from Neutral at Piper Sandler
    03/03/21 Piper Sandler
    Piper stays Neutral Patterson despite execution due to 'lingering uncertainty'
    PDCO Patterson Companies
    $30.95 /

    -4.18 (-11.90%)

    PDCO Patterson Companies
    $30.95 /

    -4.18 (-11.90%)

    Periodicals
    BuzzFeed close to go-public deal with 890 5th Avenue Partners, WSJ reports » 18:11
    06/23/21
    06/23
    18:11
    06/23/21
    18:11
    ENFA

    890 5th Avenue Partners

    $9.79 /

    -0.01 (-0.10%)

    BuzzFeed is nearing a…

    BuzzFeed is nearing a deal to go public via a merger with special purpose acquisition company 890 5th Avenue Partners, the Wall Street Journal's Benjamin Mullin reports, citing people familiar with the situation. BuzzFeed founder and CEO Jonah Peretti could announce an agreement with the blank check company as soon as this week, Mullin says. Reference Link

    ShowHide Related Items >><<
    ENFA 890 5th Avenue Partners
    $9.79 /

    -0.01 (-0.10%)

    ENFA 890 5th Avenue Partners
    $9.79 /

    -0.01 (-0.10%)

    Syndicate
    Doximity 23.3M share IPO priced at $26.00 » 18:05
    06/23/21
    06/23
    18:05
    06/23/21
    18:05
    DOCS

    Doximity

    /

    +

    The deal priced above the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    • 24
      Jun
    Syndicate
    Confluent 23M share IPO priced at $36.00 » 18:04
    06/23/21
    06/23
    18:04
    06/23/21
    18:04
    CFLT

    Confluent

    /

    +

    The deal priced above the…

    The deal priced above the $29.00-$33.00 range. Morgan Stanley, JPMorgan, Goldman Sachs, Citi, BofA, Credit Suisse, Barclays, Deutsche Bank, UBS and Wells Fargo are acting as joint book running managers for the offering.

    ShowHide Related Items >><<
    • 24
      Jun
    Syndicate
    Portage Biotech files to sell common stock, no amount given » 17:50
    06/23/21
    06/23
    17:50
    06/23/21
    17:50
    PRTG

    Portage Biotech

    $35.28 /

    +2.38 (+7.23%)

    Cantor Fitzgerald and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    • 24
      Jun
    Initiation
    PayPal initiated with a Buy at DA Davidson » 17:49
    06/23/21
    06/23
    17:49
    06/23/21
    17:49
    PYPL

    PayPal

    $288.11 /

    +1.22 (+0.43%)

    DA Davidson initiated…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PYPL PayPal
    $288.11 /

    +1.22 (+0.43%)

    PYPL PayPal
    $288.11 /

    +1.22 (+0.43%)

    12:16 Today Credit Suisse
    PayPal pricing update raises confidence in five-year outlook, says Credit Suisse
    06/21/21 BofA
    PayPal's announced price increase already in guidance, says BofA
    06/21/21 Barclays
    PayPal price increase to bring 2022 earnings upside, says Barclays
    05/07/21 BMO Capital
    PayPal price target raised to $256 from $241 at BMO Capital
    PYPL PayPal
    $288.11 /

    +1.22 (+0.43%)

    PYPL PayPal
    $288.11 /

    +1.22 (+0.43%)

    PYPL PayPal
    $288.11 /

    +1.22 (+0.43%)

    PYPL PayPal
    $288.11 /

    +1.22 (+0.43%)

    Initiation
    Square initiated with a Buy at DA Davidson » 17:38
    06/23/21
    06/23
    17:38
    06/23/21
    17:38
    SQ

    Square

    $238.66 /

    +2.68 (+1.14%)

    DA Davidson analyst…

    DA Davidson analyst Christopher Brendler initiated coverage of Square with a Buy rating and $275 price target.

    ShowHide Related Items >><<
    SQ Square
    $238.66 /

    +2.68 (+1.14%)

    SQ Square
    $238.66 /

    +2.68 (+1.14%)

    05/25/21 Baird
    Square comps starting to get more difficult, says Baird
    05/20/21 Tigress Financial
    Square shares have close to 50% upside potential, says Tigress Financial
    05/10/21 BMO Capital
    Square price target raised to $269 from $237 at BMO Capital
    05/07/21 JPMorgan
    Square price target raised to $300 from $250 at JPMorgan
    SQ Square
    $238.66 /

    +2.68 (+1.14%)

    SQ Square
    $238.66 /

    +2.68 (+1.14%)

    SQ Square
    $238.66 /

    +2.68 (+1.14%)

    SQ Square
    $238.66 /

    +2.68 (+1.14%)

    Conference/Events
    G-III Apparel participates in a conference call with UBS » 17:38
    06/23/21
    06/23
    17:38
    06/23/21
    17:38
    GIII

    G-III Apparel

    $32.57 /

    +0.53 (+1.65%)

    Consumer Goods Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GIII G-III Apparel
    $32.57 /

    +0.53 (+1.65%)

    GIII G-III Apparel
    $32.57 /

    +0.53 (+1.65%)

    06/08/21 B. Riley
    G-III Apparel price target raised to $41 from $39 at B. Riley
    06/08/21 Barclays
    G-III Apparel price target raised to $30 from $27 at Barclays
    03/19/21 B. Riley
    G-III Apparel price target raised to $38 from $33 at B. Riley Securities
    03/19/21 Barclays
    G-III Apparel price target raised to $27 from $24 at Barclays
    GIII G-III Apparel
    $32.57 /

    +0.53 (+1.65%)

    GIII G-III Apparel
    $32.57 /

    +0.53 (+1.65%)

    Conference/Events
    UBS quantitative analyst to hold analyst/industry conference call » 17:35
    06/23/21
    06/23
    17:35
    06/23/21
    17:35

    Analysts provide Quant…

    Analysts provide Quant insights and discuss challenges for central banks with Randall Kroszner, former member of the Federal Reserve Board on an Analyst/Industry conference call to be held on June 24 at 9 am.

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.